Molecula Maxima

About

Q&A

What is Molecula Maxima's primary focus?

Molecula Maxima is developing a programming environment for the creation of new genetically modified organisms and drugs, aiming to make synthetic biology accessible to software developers and engineers.

What tools does Molecula Maxima offer to engineers?

Engineers can use Molecula Maxima's Synthetic bioprogramming language and the Cytostudio IDE to design, debug, compile, and optimize chemically synthesized genes.

When was Molecula Maxima founded?

Molecula Maxima was founded in January 2015.

What is the current status of Molecula Maxima?

Molecula Maxima is currently inactive, as of December 2017.

What is Molecula Maxima's primary sector?

Molecula Maxima's primary sector is Health Tech & Life Sciences.

How many employees does Molecula Maxima have?

Molecula Maxima has 1-10 employees.

What is Molecula Maxima's current funding stage?

Molecula Maxima is in the Pre-Funding stage.

Who is the CEO of Molecula Maxima?

Eliad Moshe is the CEO of Molecula Maxima.

Sectors & technology

Highlights

Tags